Data fabrication of nifedipine sparks debate

Published: 2008-03-06 06:59:00

Updated: 2008-03-06 06:59:00

BayerSchering HealthCare's claim that local nipedipine makers fabricated bioequivalence test data due to technical limitation in plasma concentrations of nifedipine for at lease 24 hours is groundless, according to Pharmirae, a local importer of Whanin Pharm's Nifel S 30mg.

In a statement rele...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK